JAPAN OPENS ARMS TO NUVASIVE’S COROENT (Orthopedics This Week)
NuVasive, Inc’s CoRoent Large Impacted and CoRoent Large Tapered titanium alloy implants have been given the official green light in Japan.
The company announced on December 17, regulatory shonin approval from the nation’s regulatory agency. Shonin allows NuVasive to participate in the world’s second largest spine market with cervical solution. In 2005, according to law firm Morgan Lewis, the Japanese medical device market was more than 2.5 trillion yen, of which imports accounted for 1.0 trillion yen. (One yen equals $1.)
“This is an exciting stepping stone for NuVasive! For several years, we have been thoughtfully laying the groundwork and making the investments to support a direct operation in Japan, a market estimated to be close to $400 million in size. We are proud to see all of those efforts coming to fruition so that our revenue ramp can begin in earnest at the start of the first quarter.
“We look forward to the opportunity to introduce Japanese surgeons and patients to NuVasive; first to our game changing portfolio of cervical and posterior thoraco-lumbar solutions, and then, upon further regulatory approval, t...
